Rapid Nutrition PLC (RPNRF)
10.00
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Rapid Nutrition Max Drawdown (5Y): 99.98% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.98% |
March 31, 2024 | 99.98% |
February 29, 2024 | 99.98% |
January 31, 2024 | 99.98% |
December 31, 2023 | 99.98% |
November 30, 2023 | 99.98% |
October 31, 2023 | 99.98% |
September 30, 2023 | 99.98% |
August 31, 2023 | 99.98% |
July 31, 2023 | 99.98% |
June 30, 2023 | 99.98% |
May 31, 2023 | 99.59% |
April 30, 2023 | 99.49% |
March 31, 2023 | 99.49% |
February 28, 2023 | 99.17% |
January 31, 2023 | 99.17% |
December 31, 2022 | 99.17% |
November 30, 2022 | 98.96% |
October 31, 2022 | 98.37% |
September 30, 2022 | 97.95% |
August 31, 2022 | 96.95% |
July 31, 2022 | 95.91% |
June 30, 2022 | 95.91% |
May 31, 2022 | 95.91% |
April 30, 2022 | 95.91% |
Date | Value |
---|---|
March 31, 2022 | 93.88% |
February 28, 2022 | 93.88% |
January 31, 2022 | 93.88% |
December 31, 2021 | 93.88% |
November 30, 2021 | 89.94% |
October 31, 2021 | 89.94% |
September 30, 2021 | 89.94% |
August 31, 2021 | 89.94% |
July 31, 2021 | 89.94% |
June 30, 2021 | 89.94% |
May 31, 2021 | 89.94% |
April 30, 2021 | 81.50% |
March 31, 2021 | 81.50% |
February 28, 2021 | 81.50% |
January 31, 2021 | 81.50% |
December 31, 2020 | 81.50% |
November 30, 2020 | 81.50% |
October 31, 2020 | 81.50% |
September 30, 2020 | 81.50% |
August 31, 2020 | 81.50% |
July 31, 2020 | 81.50% |
June 30, 2020 | 81.50% |
May 31, 2020 | 81.50% |
April 30, 2020 | 81.50% |
March 31, 2020 | 81.50% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
75.00%
Minimum
May 2019
99.98%
Maximum
Jun 2023
89.79%
Average
89.94%
Median
May 2021
Max Drawdown (5Y) Benchmarks
LivaNova PLC | 73.87% |
Alterola Biotech Inc | 99.92% |
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |